Kolbl H - Search Results

1

4-Epidoxycycline: an alternative to doxycycline to control gene expression in conditional mouse models.

Eger K, Hermes M, Uhlemann K, Rodewald S, Ortwein J, Brulport M, Bauer AW, Schormann W, Lupatsch F, Schiffer IB, Heimerdinger CK, Gebhard S, Spangenberg C, Prawitt D, Trost T, Zabel B, Sauer C, Tanner B, Kolbl H, Krugel U, Franke H, Illes P, Madaj-Sterba P, Bockamp EO, Beckers T, Hengstler JG. Eger K, et al. Among authors: kolbl h. Biochem Biophys Res Commun. 2004 Oct 22;323(3):979-86. doi: 10.1016/j.bbrc.2004.08.187. Biochem Biophys Res Commun. 2004. PMID: 15381096

2

Dephosphorylation of p-ERK1/2 in relation to tumor remission after HER-2 and Raf1 blocking therapy in a conditional mouse tumor model.

Hausherr CK, Schiffer IB, Gebhard S, Banić A, Tanner B, Kolbl H, Thoenes E, Beckers T, Spangenberg C, Prawitt D, Trost T, Zabel B, Oesch F, Hermes M, Hengstler JG. Hausherr CK, et al. Among authors: kolbl h. Mol Carcinog. 2006 May;45(5):302-8. doi: 10.1002/mc.20157. Mol Carcinog. 2006. PMID: 16496387

3

ERBB2 induces an antiapoptotic expression pattern of Bcl-2 family members in node-negative breast cancer.

Petry IB, Fieber E, Schmidt M, Gehrmann M, Gebhard S, Hermes M, Schormann W, Selinski S, Freis E, Schwender H, Brulport M, Ickstadt K, Rahnenführer J, Maccoux L, West J, Kölbl H, Schuler M, Hengstler JG. Petry IB, et al. Among authors: kolbl h. Clin Cancer Res. 2010 Jan 15;16(2):451-60. doi: 10.1158/1078-0432.CCR-09-1617. Epub 2010 Jan 12. Clin Cancer Res. 2010. PMID: 20068093

4

Nuclear expression of apurinic/apyrimidinic endonuclease increases with progression of ovarian carcinomas.

Tanner B, Grimme S, Schiffer I, Heimerdinger C, Schmidt M, Dutkowski P, Neubert S, Oesch F, Franzen A, Kölbl H, Fritz G, Kaina B, Hengstler JG. Tanner B, et al. Among authors: kolbl h. Gynecol Oncol. 2004 Feb;92(2):568-77. doi: 10.1016/j.ygyno.2003.10.037. Gynecol Oncol. 2004. PMID: 14766249

5

The humoral immune system has a key prognostic impact in node-negative breast cancer.

Schmidt M, Böhm D, von Törne C, Steiner E, Puhl A, Pilch H, Lehr HA, Hengstler JG, Kölbl H, Gehrmann M. Schmidt M, et al. Among authors: kolbl h. Cancer Res. 2008 Jul 1;68(13):5405-13. doi: 10.1158/0008-5472.CAN-07-5206. Cancer Res. 2008. PMID: 18593943 Free article.

6

Seeger A, Kölbl H, Petry IB, Gebhard S, Battista MJ, Böhm D, Steiner E. Seeger A, et al. Among authors: kolbl h. Gynecol Oncol. 2012 Apr;125(1):200-7. doi: 10.1016/j.ygyno.2011.12.443. Epub 2011 Dec 28. Gynecol Oncol. 2012. PMID: 22210468

7

Long-term prognostic significance of HER-2/neu in untreated node-negative breast cancer depends on the method of testing.

Schmidt M, Lewark B, Kohlschmidt N, Glawatz C, Steiner E, Tanner B, Pilch H, Weikel W, Kölbl H, Lehr HA. Schmidt M, et al. Among authors: kolbl h. Breast Cancer Res. 2005;7(2):R256-66. doi: 10.1186/bcr991. Epub 2005 Jan 26. Breast Cancer Res. 2005. PMID: 15743506 Free PMC article.

8

Diabetes mellitus is a multivariate independent prognostic factor in endometrial carcinoma: a clinicopathologic study on 313 patients.

Steiner E, Plata K, Interthal C, Schmidt M, Faldum A, Hengstler JG, Sakuragi N, Watari H, Yamamoto R, Kölbl H. Steiner E, et al. Among authors: kolbl h. Eur J Gynaecol Oncol. 2007;28(2):95-7. Eur J Gynaecol Oncol. 2007. PMID: 17479668

9

[Inhibins and Activin A in hypertensive Disorders of Pregnancy and HELLP-Syndrome].

Seufert R, Neubert S, Tanner B, Schaffrath M, Pollow K, Kölbl H. Seufert R, et al. Among authors: kolbl h. Zentralbl Gynakol. 2004 Jun;126(3):148-53. doi: 10.1055/s-2004-822592. Zentralbl Gynakol. 2004. PMID: 15236099 German.

10

Phase II study of fulvestrant 250 mg/month in patients with recurrent or metastatic endometrial cancer: a study of the Arbeitsgemeinschaft Gynäkologische Onkologie.

Emons G, Günthert A, Thiel FC, Camara O, Strauss HG, Breitbach GP, Kölbl H, Reimer T, Finas D, Rensing K; Arbeitsgemeinschaft Gynäkologische Onkologie (AGO). Emons G, et al. Among authors: kolbl h. Gynecol Oncol. 2013 Jun;129(3):495-9. doi: 10.1016/j.ygyno.2013.02.039. Epub 2013 Mar 13. Gynecol Oncol. 2013. PMID: 23500091 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

212 results

Search Page

Filters